HAMP and Alzheimer disease: In congruence with our study, Fpn is decreased in human AD and APP transgenic mouse brains and in response to ischaemia and inflammation [[33], [34], [35]], the latter inducing hepcidin-upregulation to internalise and degrade Fpn [34].